PRCT procept-biorobotics.com Market Cap to Net Assets Ratio

Official company branding of PROCEPT BioRobotics Corp (PRCT)

This price action chart for PROCEPT BioRobotics (PRCT) features a company that developed the AquaBeam automated system for AI-powered precision prostate tissue removal. Business revenues are based on the sale of high-tech installations and the recurring sale of ancillary components to clinics. Leveraging the hydroablation method, the firm is rapidly capturing the niche by bypassing standard approaches, while the key metric stands at 3.34.

PRCT Procept: Market Value to Book Value in the range 07/04/2022 - 10/26/2026
Original product of PROCEPT BioRobotics Corp

This ratio reflects the premium of the business's market value over its net assets, measuring the extent to which quotes are inflated relative to book capital. By analyzing the price-to-book history, an investor can discern market expectations for the capitalization of the intellectual potential of PROCEPT BioRobotics (PRCT), where a high valuation is justified by the aggressive hiring of top engineers and the incentivization of specialists through stock option programs.

Competitor analysis

DXCM - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple penumbrainc.com|Novanta (NOVT) - Market Cap to Net Assets Ratio|Market Cap to Book Value Multiple Haemonetics Corp|Inspire Sleep (INSP) - Market Capitalization to Book Value Ratio|Market Value to Book Value CONMED Inc. (CNMD)|PLSE: Market Capitalization to Book Value Ratio|inmodemd.com - Market-to-Book Ratio|Market Value to Book Value Ratio Picard Medical (PMI)|SRDX - Market Value to Book Value|SENS: Market Capitalization to Book Value Ratio|NPCE (NeuroPace Medical) - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Tactile Systems Technology, Inc. TCMD|Market Capitalization to Net Assets sanuwave.com|Outset Medical - Market Capitalization to Book Value Ratio|Market-to-Book Ratio smartvest.com ELMD|Market Cap to Net Assets Ratio LNSR (LENSAR, Inc)|RCEL - Market Capitalization to Book Value Ratio|Market Cap to Net Assets Ratio Profound Medical Corporation PROF|BDMD - Market Cap to Book Value Multiple|edap-tms.com - Market Capitalization to Book Value Ratio|Apyx Medical Corporation (APYX) - Market Capitalization to Book Value|Market Capitalization to Book Value Ratio ICCM|Market Cap to Net Assets Ratio Pulmonx Corp. (LUNG)|TELA Bio, Inc. (TELA) - Market Cap to Net Assets Ratio|Market Value to Book Value CTSO (cytosorbents.com)|Sensus Healthcare - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Zynex Medical ZYXI|ECOR (electroCore Medical) - Market Capitalization to Book Value Ratio|RBOT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio inspira-technologies.com|seastarmedical.com (ICU) - Capitalization to Book Value Ratio|IRIX: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Intelligent Bio|Market Capitalization to Book Value Ratio XAIR (Beyond Air, Inc.)|Market Cap to Net Assets Ratio Profusa, Inc (PFSA)|Market Capitalization to Book Value Ratio SSKN (STRATA Skin Sciences, Inc.)|GlucoTrack Inc. - Market Capitalization to Book Value Ratio|NAOV - Market Value to Book Value Ratio|Venus Concept Inc (VERO) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio CHF Solutions NUWE|Aethlon Medical Corp (AEMD) - Market Value to Book Value|Market Capitalization to Book Value Ratio ASXC (Asensus Surgical Inc)|Market-to-Book Ratio AVGR|BSGM: Market Value to Book Value Ratio|Market Value to Equity Ratio Cutera Inc. CUTR|Market Cap to Net Assets Ratio KNW (Know Labs Corp)|Market Capitalization to Book Value Ratio Inari Medical Corp NARI|Market Capitalization to Book Value Ratio NVRO (Nevro Corp.)|RSLS: Market Capitalization to Book Value|Market Value to Book Value Ratio Silk Road Medical (SILK)